Canagliflozin Enantiomer Impurity |
|
|---|---|
| CAT. No : | C960001 |
| CAS. No : | NA |
| Mol. F : | C24H25FO5S |
| Mol. Wt : | 444.52 g/mol |
| Synonyms : | (1S,2S,3R,4R,6S)-4-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)cyclohexane-1,2,3-triol;Canagliflozin L-Glucitol |
| Chemical Name : | (2R,3S,4S,5R,6S)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| Stock Status : | Custom Synthesis |
- Buy High-Quality Canagliflozin Enantiomer Impurity from Simson Pharma Limited at best competitive price.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Canagliflozin Enantiomer Impurity for Method Validation | Canagliflozin Enantiomer Impurity Reference Standard | Canagliflozin Enantiomer Impurity for ANDA Filing | Canagliflozin Enantiomer Impurity for Forced Degradation Studies | Canagliflozin Enantiomer Impurity Identification Standards | Canagliflozin Enantiomer Impurity for DMF Filing | Buy high quality Canagliflozin Enantiomer Impurity | Purchase Canagliflozin Enantiomer Impurity | Canagliflozin Enantiomer Impurity suppliers | Canagliflozin Enantiomer Impurity manufacturers | Canagliflozin Enantiomer Impurity price | Canagliflozin Enantiomer Impurity exporter | Order Canagliflozin Enantiomer Impurity | Enquire Canagliflozin Enantiomer Impurity | Canagliflozin Enantiomer Impurity cost | Canagliflozin Enantiomer Impurity Supplier | Canagliflozin Enantiomer Impurity Distributor
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
